![Andrew Partridge](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andrew Partridge
Corporate Officer/Principal presso
GRAIL, INC.
Patrimonio netto: 22 M $ in data 30/09/2026
Profilo
Andrew Partridge is Chief Commercial Officer at GRAIL, Inc. since 2022.
Formerly, Mr. Partridge was Chief Commercial Officer & Executive VP at Turning Point Therapeutics, Inc. from 2020 to 2022, Chief Commercial Officer & Executive VP at Centrexion Therapeutics Corp.
from 2018 to 2020, VP & Head-North America Commercial Operations at Vertex Pharmaceuticals, Inc. from 2013 to 2018, and Executive Director-Sales & Oncology Business Unit at Amgen, Inc. from 2003 to 2013.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
GRAIL INC 0,35% | 05/10/2026 | 155.865 ( 0,35% ) | 22 M $ | 30/09/2026 |
Posizioni attive di Andrew Partridge
| Società | Posizione | Inizio |
|---|---|---|
| GRAIL, INC. | Corporate Officer/Principal | 01/05/2022 |
Precedenti posizioni note di Andrew Partridge
| Società | Posizione | Fine |
|---|---|---|
| TURG POIN | Corporate Officer/Principal | 01/05/2022 |
| CENTREXION THERAPEUTICS CORPORATION | Corporate Officer/Principal | 02/07/2020 |
| VERTEX PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | 01/11/2018 |
| AMGEN INC. | Vendite & Marketing | 01/01/2013 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
86
Relazioni di 1° grado
5
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Vertex Pharmaceuticals, Inc.
 Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
Centrexion Therapeutics Corp.
 Centrexion Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Develops non-opioid clinical stage medicines for the treatment of chronic pain | Health Technology |
Turning Point Therapeutics, Inc.
 Turning Point Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage structure based drug design company for cancer diseases | Health Technology |
GRAIL, Inc.
 GRAIL, Inc. Medical SpecialtiesHealth Technology Manufactures cancer detection test kits and provides related services | Health Technology |
